• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Advisory Committees

  • Print
  • Share
  • E-mail

Welcome to VMAC: Microbial Food Safety of Cefquinome

Welcome to VMAC:
Microbial Food Safety of Cefquinome

Coments by
Dr. Stephen Sundlof, D.V.M., Phd
Center for Veterinary Medicine
September 25, 2006
Rockville, MD

Welcome to VMAC slide one

Slide 2

Committee Members

  • Arthur L. Craigmill, Ph.D, University of California
    - veterinary toxicology
  • Corri Brown, D.V.M., Ph.D., University of Georgia
    - pathology
Welcome to VMAC - slide two

Slide 3 

Committe Members

  • John R. Gilsson, D.V.M.,
    MAM, Ph. D., University of Georgia
    - avian medicine
  • Sam Groseclose, D.V.M,
    MPH, Centers for Diease Control and Prevention
    - public health/epidemiology
Welcome to VMAC - slide three

Slide 4

Committe Members

  • Sherman W. (Skip) Jack,
    D.V.M., Ph.D., Mississippi State
    - minor use/minor species veterinary medicine
  • Gregory Jaffe, Center for Science in the Public Interest
    - consumer representative
Welcome to VMAC - slide four

Slide 5

Committe Members

  • John J. McGlone, Ph.D.,
    Texas Tech University and Health Sciences Center
    - animal science
  • Mark G. Papich, D.V.M., Ph.D,
    North Carolina State University
Welcome to VMAC - slide five

Slide 6

Committee Members

  • M. Gatz Riddell, Jr., D.V.M
    American Association of Bovine Practitioners
    - food animal medicine
  • Richard A. Sams, Ph.D., The Ohio State University
    - chemistry
Welcome to VMAC - slide six

Slide 7


  • James E. Leggett, Jr., M.D.,
    Oregon Health Sciences University
    - infectious diseases
  • L. Barth Reller, M.D.,
    D.T.M.&H., Duke University Medical Center
    - infectious diseases
Welcome to VMAC - slide seven

Slide 8

Purpose of Meeting

  • VMAC input on microbial food safety of antimicrobial for food animal
    - concept in Guidance for industry
    - second VMAC review of antimicrobial animal drug
    - 2004 review of tulathromycin
Welcome to VMAC - slide eight

Slide 9

Reason for Review

  • 4th generation cephaosporin
    - important to human medicine
    - 3rd generation considered "critically important" to human health
  • Review appropriate under Guidance
Welcome to VMAC - slide nine

Slide 10

Thank you for Coming

Valuable assistance from VMAC members, consultants

Welcome to VMAC - slide ten